Stories
Nephrocare Health Services Block Deal: Investors to Sell 9% Stake at ’705/Share
- •Existing investors of Nephrocare Health Services are set to sell up to 8.9% of the company's total equity, valued at ’650 crore, through a block deal on Thursday.
- •The offer price for the block deal is fixed at ’705 per share, representing approximately a 5% discount to the stock's last closing price.
- •The sellers include Investcorp Private Equity Fund II, Healthcare Parent Limited, Edoras Investment Holdings Pte Ltd, Quadria Capital India Fund III, and several other investment entities and family trusts.
- •Nephrocare Health Services, operating under the NephroPlus brand, is India's largest dialysis service provider, holding over 50% of the organized dialysis market.
- •The company aims for 15-20% revenue growth over the next 3-4 years, driven by expansion in India and overseas, acquisitions, and new capacity additions, with a focus on entering new international markets annually.
Key Questions Answered
Existing investors of Nephrocare Health Services are offering up to an 8.9% stake worth ₹650 crore through a block deal. The offer price is set at ₹705 per share, representing about a 5% discount to the stock's last closing price.
The sellers participating in the block deal include Investcorp Private Equity Fund II, Healthcare Parent Limited, Investcorp India Private Equity Opportunity Limited, Edoras Investment Holdings Pte Ltd, Quadria Capital India Fund III, Bessemer Venture Partners Trust, Vikram Vuppala, Viraaj Family Trust, and Manvi Family Trust.
Operating under the NephroPlus brand, Nephrocare Health Services is India's largest dialysis service provider, running 521 clinics globally as of 9M FY26. This includes 469 clinics across 290 cities in India spanning 21 states and four Union Territories, alongside its international presence in countries like the Philippines, Uzbekistan, and Nepal.
